Regarding 6-week mortality, our analysis showed that it correlated with FABP2, albumin, CRP levels, severity of liver disease, and the presence of severe cirrhosis-related complications, including portal vein thrombosis and hepatocellular carcinoma. The gene discussed is ALB; the disease is Portal vein thrombosis.